In a previous article published on May 6, 2013, I discussed how an innovative product, coupled with a change in business model, helped LifeVantage Corporation (LFVN) in achieving significant revenue growth. Since then, things have continued to improve for the Sandy, Utah-based company.
As I discussed before, LifeVantage is looking to capitalize on the fast growing anti-aging market. The multi-billion dollar anti-aging market is highly fragmented, though. However, LifeVantage, with its innovative product called Protandim, has been able to create a niche for itself.
Protandim is a daily dietary supplement, which helps in fighting oxidative stress through Nrf2 activation. As I mentioned before, Protandim's success can be mainly attributed to David Brown, who serves...
Only subscribers can access this article, which is part of the PRO research library covering 3,570 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: